Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 302 for “"Cellular models"”.
-
Developing cellular models for human myopathies
… and KLHL40, by creating and characterizing cellular disease models in hopes of validating findings from animal models. Future studies will be aimed at creating therapeutics for KLHL30 and KLHL40 deficient neuromuscular diseases.
-
DERIVATION OF NOVEL CELLULAR MODELS OF HEPATOCELLULAR CARCINOMA
… cause of cancer death worldwide, with hepatocellular carcinoma (HCC) being the most common form. To date, only a few drugs have been approved by the FDA for advanced HCC patients, while hundreds new drugs have failed in different stages of clinical trials in the past 11 years. Those drugs …
-
Metabolomics of Mammalian and Cellular Models of Aging
… electrochemical detection in combination with cellular assay methods have great potential for metabolite profiling of de novo purine biosynthesis pathway mutants, identification of novel genetic defects of purine metabolism in humans, and elucidating the regulation of this critical metabolic …
-
DISEASE MODELING AND MODIFICATION IN CELLULAR MODELS OF BARTH SYNDROME
… the importance of evaluating downstream cellular defects in a tissue-targeted manner.
-
ASSESSING THE PATHOGENESIS OF MULTIPLE SYSTEM ATROPHY THROUGH CELLULAR MODELS
… and Dementia with Lewy bodies, the main intracellular localization of alpha-synuclein aggregates in MSA is not the neuron, but the oligodendrocyte. An effective therapy is not available yet. The pathogenesis of the disease is almost completely unknown and the available models, mainly …
-
Neuron-Microglia Interactions in Cellular Models of Familial Parkinson's Disease
Η νόσος του Πάρκινσον (ΝΠ), που χαρακτηρίζεται από προοδευτική απώλεια ντοπαμινεργικών νευρώνων στον κοιλιακό μέσο εγκέφαλο, είναι η δεύτερη συχνότερη νευροεκφυλιστική νόσος. Τα ιστοπαθολογικά χαρακτηριστικά περιλαμβάνουν εγκλείσματα σωματιδίων Lewy που σχηματίζονται από τη συσσώρευση της κακώς …
-
Cellular models for characterisation of MINA53, a 2-oxoglutarate-dependent dioxygenase
… to regulate a variety of essential cellular processes in mammals, including; chromatin remodeling, extra-cellular matrix formation and oxygen sensing.</p> <p>The work in this thesis focuses on a 2OG Oxygenase termed Myc-Induced Nuclear Antigen (MINA53). This enzyme has been …
-
CELLULAR MODELS FOR STUDYING AND TREATING ABNORMAL CARDIAC AND NEURONAL EXCITABILITY
… to generate a biological pacemaker, that is a cellular substrate able to drive the beating rate of the host tissue. Potentially, a biological pacemaker presents several advantages compared to electronic devices: it can respond to nervous system regulation and does not need maintenance or …
-
Protein Markers and Cell Stress Responses in Cellular Models of Neurodegeneration
Η δυσλειτουργία και η συσσωμάτωση πρωτεϊνών αποτελούν χαρακτηριστικά των νευροεκφυλιστικών ασθενειών, με κάθε ασθένεια να έχει ένα ξεχωριστό ενδοκυτταρικό και εξωκυτταρικό πρωτεϊνικό προφίλ. Αυτή η διατριβή βασίζεται σε προηγούμενα δεδομένα σχετικά με τον ρόλο της APP στις κυτταρικές αποκρίσεις στο …
-
Study of pathogenetic mechanisms of Parkinson's disease in neuronal cellular models
… αSyn as the major pathogenic factor that causes cellular toxicity. Alternative strategies to tackle early steps in neurodegeneration, particularly in an unbiased approach, have lagged behind. Recent advances in patient-derived induced pluripotent stem cell (iPSC)-based models for …
-
Development and validation of cellular models for studying amyloid precursor protein isoforms.
The development and validation of cellular model for studying amyloid precursor protein isoforms. Amyloid beta peptide (Abeta) is the major constituent of neuritic plaques in the brains of patients with Alzheimer's disease (AD). Abeta is a small insoluble 39-43 amino acid peptide derived from the …
-
Leveraging cellular models of polycystic kidney disease for mechanistic discovery and therapeutic development
… by limitations in currently available research models. Here we develop gene-edited clonal tubular epithelial cells and multi-cellular kidney organoids for mechanistic and therapeutic studies of PKD. In our kidney organoid model, we utilize CRISPR base editing to generate human pluripotent stem …
-
Mapping networks of alpha-Synuclein proteostasis in cellular models of Parkinson's disease pathology
… pathological fraction of aSyn. Initial data in cellular PD models show that intracellular aSyn inclusions that form over a period of days are conjugated to K48-linked ubiquitin (Ub) chains and that the pharmacological activation of the proteasome, but not of macroautophagy, reduces the relative …
-
LIPIDOMICS UNVEILS THE ROLE OF BIOACTIVE LIPIDS IN CELLULAR MODELS OF CYSTIC FIBROSIS
… cystic fibrosis cells and the derived extracellular vesicles. The airways cells in cystic fibrosis accumulate lipids, exacerbating inflammation that can be partly reversed by myriocin therapy, which acts directly on sphingolipid synthesis and indirectly on the accrual of other lipid classes. …
-
Investigating mechanisms of TDP-43 toxicity in cellular models of amyotrophic lateral sclerosis
… of the pathogenic TDP-43 M337V mutation on cellular phenotypes in an mESC-MN model of ALS. In TDP-43 M337V mESC-MNs, I observed reduced viability, both in unstressed and oxidative stressed conditions, and impaired stress granule formation in response to oxidative stress compared to TDP-43 WT …
-
Pharmacological inhibition of the methyltransferases SUV4-20 in cellular models of Friedreich’s ataxia
… with limitations surrounding the in vitro models historically used for drug discovery. Recently, the methyltransferases SUV4-20 have been identified for their role in facilitating the partial silencing of FXN, through an increase in repressive H4K20 di- and trimethylation marks. Inhibition …
-
Optimisation of CCR7-based cellular models for future use in drug development programmes
… and functional role across selected cancer models, whilst simultaneously attempting to establish a transient and validated CCR7-expressing cell-based system to support future high-throughput drug screening efforts. These findings provide insights into the oncogenic role of CCR7 and establish …
Page 1 of 16